Screener
Kyverna Therapeutics, Inc. KYTX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 1,343 | 1,546 |
| Operating lease right-of-use assets | 8,192 | 3,568 |
| Finance lease right-of-use assets | 198 | 305 |
| Other non-current assets | 5,014 | 4,903 |
| Total assets | $257,024 | $293,826 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $11,603 | $5,306 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Kyverna Therapeutics, Inc. (KYTX) reported deferred tax assets and other non-current assets of $5.01M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 37.6% year-over-year, from $3.64M to $5.01M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 20.9% compound annual growth rate (CAGR), from $3.36M to $4.9M.
Ask your AI about Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude